Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugs

Table 2 Overview of investigated drugs and concentrations

Drug	Manufacturer	Lot No.	Dilution media	Concentration after dilution (mg/ml)
Acyclovir sodium	Hospira	X171213AA X101213AB A101193AA A101213AA Y131213AB	Glucose 50 mg/ml	5 mg/ml
Ampicillin sodium	Bristol-Myers Squibb	2A00936 3E02641 0059774 3J01732 3L01792 3F02259 1E00687 1J00117 1C00905 0G56375 1A00661 0L60962 0J63206 3C02634	NaCl 9 mg/ml	50 mg/ml
	APP Pharmaceuticals	1K10AK
	SAGENT Pharmaceuticals	P3667
Ondansetron hydrochloride	Copyfarm	9278 18DI32602 18D350301	Glucose 50 mg/ml	0.2 mg/ml
	Fresenius Kabi	18F321601 18G207503 18G157402 18F321601 18E272402 18E183801 19E18380
	Accord Healthcare	N08669 M13242
Paracetamol	Bristol-Myers Squibb	0M44297 1E63971	Undiluted	10 mg/ml
	Fresenius Kabi	14GC20 14GF36 16FD0093 16EM0155
	B. Braun	13486404 13487404 14382407
	Actavis	14EE30 14EH47 16EM0155

ISSN: 1475-2891